Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion type Assertion NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_head.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion evidence source_evidence_literature NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion SIO_000772 20884628 NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion wasDerivedFrom befree-20150227 NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion wasGeneratedBy ECO_0000203 NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.